{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:34:42Z","timestamp":1767854082637,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.contraception.2005.03.006","type":"journal-article","created":{"date-parts":[[2005,6,14]],"date-time":"2005-06-14T11:25:33Z","timestamp":1118748333000},"page":"187-191","source":"Crossref","is-referenced-by-count":22,"title":["Randomized assignment to copper IUD or depot-medroxyprogesterone acetate: feasibility of enrollment, continuation and disease ascertainment"],"prefix":"10.1016","volume":"72","author":[{"given":"Paul J.","family":"Feldblum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Caraway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Bahamondes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El-Shafei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do","family":"Quan Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silver","family":"Wevill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Condon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2005.03.006_bib1","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/00006254-199612000-00013","article-title":"Intrauterine devices and pelvic inflammatory disease: evolving perspectives on the data","volume":"51","author":"Burkman","year":"1996","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.contraception.2005.03.006_bib2","first-page":"1","article-title":"The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study","volume":"72","author":"Lee","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2005.03.006_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(84)90074-X","article-title":"PID associated with fertility regulating agents","volume":"30","author":"Task Force on Intrauterine Devices, World Health Organization","year":"1984","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.03.006_bib4","first-page":"1","article-title":"Type of intrauterine device and the risk of pelvic inflammatory disease","volume":"62","author":"Lee","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2005.03.006_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0140-6736(92)91904-M","article-title":"Intrauterine devices and pelvic inflammatory disease: an international perspective","volume":"339","author":"Farley","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2005.03.006_bib6","series-title":"Improving access to quality care in family planning: medical eligibility criteria for contraceptive use","author":"World Health Organization, Family and Reproductive Health","year":"1996"},{"key":"10.1016\/j.contraception.2005.03.006_bib7","series-title":"1998 Guidelines for treatment of sexually transmitted diseases","author":"Centers for Disease Control and Prevention","year":"1998"},{"key":"10.1016\/j.contraception.2005.03.006_bib8","first-page":"113","article-title":"Criteria for diagnosis and grading of salpingitis","volume":"61","author":"Hager","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2005.03.006_bib9","series-title":"Management of sexually transmitted diseases","author":"Global Programme on AIDS","year":"1997"},{"key":"10.1016\/j.contraception.2005.03.006_bib10","first-page":"48","article-title":"Sexually transmitted diseases treatment guidelines 2002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR"},{"key":"10.1016\/j.contraception.2005.03.006_bib11","author":"Contraceptive Technology","year":"2004"},{"key":"10.1016\/j.contraception.2005.03.006_bib12","first-page":"142","article-title":"Success of randomization in a controlled contraceptive experiment","volume":"11","author":"Fuertes-de la Haba","year":"1973","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2005.03.006_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0010-7824(83)90009-4","article-title":"The effects of three different regimens of oral contraceptives and three different intrauterine devices on the levels of hemoglobin, serum iron and iron binding capacity in anemic women","volume":"27","author":"Rivera","year":"1983","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.03.006_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0010-7824(90)90058-4","article-title":"Comparison of the clinical performance, contraceptive efficacy and acceptability of levonorgestrel-releasing IUD and Norplant-2 implants in China","volume":"41","author":"Ji","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.03.006_bib15","first-page":"764","article-title":"The diaphragm with and without spermicide: a randomized, comparative efficacy trial","volume":"40","author":"Bounds","year":"1995","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2005.03.006_bib16","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(00)02699-4","article-title":"Intrauterine device and upper-genital-tract infection","volume":"356","author":"Grimes","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2005.03.006_bib17","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.266.18.2594","article-title":"Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model","volume":"266","author":"Kahn","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2005.03.006_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0010-7824(03)00136-7","article-title":"Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety","volume":"68","author":"Westhoff","year":"2003","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405000983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405000983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T23:51:32Z","timestamp":1548460292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782405000983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0010782405000983"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2005.03.006","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}